openPR Logo
Press release

United States Cell Line Development & Bio Production Market Growth Driven by Biologics & Vaccine Manufacturing | Key Players: American Type Culture Collection, Lonza Group AG, Thermo Fisher Scientific Inc, GE Healthcare

09-29-2025 09:07 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Cell Line Development Market

Cell Line Development Market

The Cell line Development Market will grow from USD 5.76 billion in 2024 to USD 13.39 billion by 2033, at a CAGR of 9.9% (2025-2033).

The most recent report published by DataM Intelligence indicates that the "Cell Line Development and Bio Production Market" is likely to accelerate significantly in the next few years. The Cell Line Development and Bio Production Market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The Cell Line Development and Bio Production Market study includes information on market factors such as the market dynamics, drivers, restraints, challenges, threats, potential growth opportunities, market trends, development patterns, financial information, latest technologies, innovations, leading competitors, and regional analysis of the market.

Download Latest Sample of This Strategic Report (Get Higher Priority for Corporate Email ID):-@ https://www.datamintelligence.com/download-sample/cell-line-development-market?ophp

The list of Key Players Profiled in the study includes:- American Type Culture Collection, Lonza Group AG, Thermo Fisher Scientific Inc, GE Healthcare, Sigma Aldrich Corporation ,Selexis SA, Promega Corporation, Corning Inc, WuXiApp Tec Inc, Sartorious AG.

United States: Recent Industry Developments

✅ In August 2025, Lonza expanded its cell line development services in Maryland with a new state-of-the-art facility.The site will accelerate monoclonal antibody and advanced biologics production for U.S. and global clients.

✅ In July 2025, Thermo Fisher Scientific launched its next-generation CHO cell line platform, boosting yields for complex biologics.The innovation integrates AI-driven process optimization to shorten development timelines.

✅ In June 2025, Catalent invested $250 million in expanding its bioproduction capacity in Indiana.The project adds high-capacity bioreactors and advanced automation systems to meet rising biologics demand.

Japan: Recent Industry Developments

✅ In August 2025, Fujifilm Diosynth Biotechnologies opened a new bioproduction site in Osaka.The facility focuses on cell line development and large-scale biologics manufacturing, reinforcing Japan's biopharma supply chain.

✅ In July 2025, Takeda Pharmaceutical partnered with RIKEN to advance stem cell-derived production platforms for next-gen biologics.The collaboration targets enhanced efficiency and scalability in regenerative medicine manufacturing.

✅ In May 2025, Kyowa Kirin invested in AI-powered cell line screening technologies for oncology drug development.The initiative aims to improve precision and reduce timelines in Japanese biopharmaceutical R&D.

Cell line development involves creating stable mammalian or microbial cells for biologic drug production, while bio production encompasses upstream and downstream manufacturing processes. Market growth is driven by biologics expansion, biosimilar pipelines, and demand for faster, scalable production systems. In the U.S., 2025 saw investments in high-throughput cell line platforms, automation technologies, and regulatory approvals supporting accelerated biologics manufacturing.

Market Dynamics:

✅Driver: Growing biologics and vaccine production needs are accelerating demand for cell line development solutions.
✅Restraints: High R&D costs and technical expertise requirements limit smaller biotech adoption.
✅Opportunities: Innovations in gene editing, high-yield production, and scalable bioprocessing expand potential.
✅Challenges: Regulatory compliance, contamination risks, and production reproducibility remain hurdles.

Segmentation Analysis of the Market:

Global Cell Line Development and Bio Production Market forecast report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market. Cell Line Development and Bio Production Market, By Types of Cell Lines (Primary Cell Lines, Continuous Cell Lines, Hybridomas, Recombinant Cell Lines), By Application(Bioproduction, Tissue Engineering Regenerative Medicines, Toxicity Testing, Research, Drug Discovery ), By Source(Mammalian Cell Lines, Non -Mammalian Cell Line), By Product(Reagent and Media, Equipment, Finished Cells, Others), By End-User ( Academics and Research Institutes, Biotech Companies, Others)

Research Methodology:

- Primary Research: This method involves collecting new and original data for a specific purpose. Primary research is often conducted through surveys, interviews, focus groups, and observation. It enables researchers to obtain first-hand information directly from the target audience, which is especially useful when researching a new or emerging market.

- Secondary Research: This method involves analyzing and synthesizing existing data from various sources such as industry reports, government publications, academic research, and online databases. Secondary research can provide researchers with valuable insights into industry trends, consumer behavior, and Cell Line Development and Bio Production market size and growth, without the need for extensive data collection.

Most research studies use a combination of both primary and secondary research methods to ensure comprehensive and accurate data analysis. The specific methodology used in a Cell Line Development and Bio Production market research study will depend on various factors such as the research objectives, the target audience, and the available resources.

Request Customized Market Entry Assessment for North America, EU, APAC: https://www.datamintelligence.com/customize/cell-line-development-market?ophp

Regional Outlook:

The following section of the report offers valuable insights into different regions and the key players operating within each of them. To assess the growth of a specific region or country, economic, social, environmental, technological, and political factors have been carefully considered. The section also provides readers with revenue and sales data for each region and country, gathered through comprehensive research. This information is intended to assist readers in determining the potential value of an investment in a particular region.

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)

South America (Brazil, Argentina, Rest of SA)

Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.
The major points covered in the table of contents:

📌 Overview: This part provides a summary of the report, as well as a broad overview of the global Cell Line Development and Bio Production Market, to offer an understanding of the nature and contents of the research study.

📌 Market Analysis: The research forecasts the market share of key segments of the Cell Line Development and Bio Production Market with accuracy and reliability. This study may be used by industry participants to make strategic investments in key growth areas of the Cell Line Development and Bio Production Market.

📌 Analysis of Leading Players' Strategies: This report can be used by market participants to acquire a competitive advantage over their rivals in the Cell Line Development and Bio Production Market.

📌 Regional Growth Analysis: The report covers all of the key areas and countries. The regional analysis will assist market players in tapping into untapped regional markets, developing unique regional strategies, and comparing the growth of all regional markets.

📌 Market Forecasts: Report purchasers will get access to precise and validated estimations of the entire market size in terms of both value and volume. The study also includes estimates for the Cell Line Development and Bio Production Market in terms of consumption, production, sales, and other factors.

Benefits of Cell Line Development and Bio Production Market Reports:

➟ Make informed decisions: The growth of an organization depends on decisions made by management. Using our market research reports, management can make business decisions based on the results obtained that support their knowledge and experience. Cell Line Development and Bio Production Market research helps to understand market trends and is therefore often performed to gain insight into customers.

➟ Get Accurate Information: Our market research provides true and accurate information, preparing organizations for any future mistakes that may occur.

➟ help you choose the right sales system: choose the precise sales system according to the Cell Line Development and Bio Production market demand, to position the product/service in the market.

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=cell-line-development-market

The report answers a number of crucial questions, including:

- Which companies dominate the global Cell Line Development and Bio Production market?

- What current trends will influence the market over the next few years?

- What are the market's opportunities, obstacles, and driving forces?

- What predictions for the future can help with strategic decision-making?

- What advantages does market research offer businesses?

Get Corporate Access to Live Cell Line Development and Bio Production Industry Intelligence Database: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Cell Line Development & Bio Production Market Growth Driven by Biologics & Vaccine Manufacturing | Key Players: American Type Culture Collection, Lonza Group AG, Thermo Fisher Scientific Inc, GE Healthcare here

News-ID: 4201427 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Medical Gas Equipment Market 2025 | Growth Drivers, Market Forecast, Competitive Landscape & Business Opportunities
United States Medical Gas Equipment Market 2025 | Growth Drivers, Market Forecas …
Market Size and Growth Global Medical Gas Equipment market is expected to reach at a Significant CAGR during the forecast period 2024-2031. Key Development: United States: Recent Industry Developments ✅ In September 2025, GSK announced a $30 billion investment in U.S. R&D and supply chain infrastructure, including $1.2 billion for advanced manufacturing facilities and AI technologies. ✅ In June 2025, CareFusion deployed portable medical gas systems for home healthcare, supporting respiratory patients. ✅ In May 2025,
United States Triple Negative Breast Cancer Market Growth Fueled by Targeted Therapies & Clinical Trials | Key Players: Merck & Co., Inc., Gilead Sciences, Inc., and F. Hoffmann-La Roche Ltd.
United States Triple Negative Breast Cancer Market Growth Fueled by Targeted The …
The global triple negative breast cancer Treatment Market reached US$ 0.95billion in 2023, with a rise to US$ 1.00billion in 2024, and is expected to reach US$ 1.66billion by 2033, growing at a CAGR of 6.6% during the forecast period 2025-2033. The most recent report published by DataM Intelligence indicates that the "Triple Negative Breast Cancer Market" is likely to accelerate significantly in the next few years. The Triple Negative Breast
United States Hadron Therapy Market 2025 | Growth Drivers, Key Players & Investment Opportunities
United States Hadron Therapy Market 2025 | Growth Drivers, Key Players & Investm …
Market Size and Growth Hadron therapy market growing at a CAGR of 10% during the forecast period 2024-2031. Key Development: United States: Recent Industry Developments ✅ In August 2025, Ion Beam Applications (IBA) announced the successful installation of its Proteus®ONE compact proton therapy system in California. The facility is expected to expand patient access to advanced cancer treatments and will commence operations by early 2026. ✅ In July 2025, Varian, a Siemens Healthineers company, received
United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Biologics Market Growth Driven by Rising Prevalence & Advanced Therapies
United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Biologics Marke …
The Global Chronic Obstructive Pulmonary Disease Drugs Market reached US$24.67 billion in 2024 and is expected to reach US$35.15 billion by 2032, growing at a CAGR of 4.9% during the forecast period 2025-2032.US$35, according to DataM Intelligence report. The most recent report published by DataM Intelligence indicates that the "Chronic Obstructive Pulmonary Disease Drugs Market" is likely to accelerate significantly in the next few years. The Chronic Obstructive Pulmonary Disease Drugs

All 5 Releases


More Releases for Cell

Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic "Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic. Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445 Current
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939 This latest report researches the industry structure, sales, revenue,
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Banking Outsourcing Market Report 2018: Segmentation by Type of Bank (Maste …
Global Cell Banking Outsourcing market research report provides company profile for Charles River Laboratories, Cryo-Cell International Inc., BioOutsource (Part of Sartorious Stedim Biotech Group)Ltd., BioReliance Corporation, BSL Bioservice Scientific Laboratories Munich GmbH, Cleancells, CordLife Group Ltd and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY